Key Sessions
Mike Vandiver
Project Launch Pad - Design Efforts for New Facility in Everett, WA
Seattle Genetics
James Warren
Bioprocess Engineering Strategies to Enhance Productivity and Yield of the Pinnacle ™ Producer Cell Line Platform, Enabling High Productivity at 2000L Scale
Ultragenyx Gene Therapy
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference - Day 2 - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Main Conference - Day 2 - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
8:00am - 8:10am10 mins
Plenary Session
Chairperson's Opening Remarks
8:10am - 8:50am40 mins
Plenary Session
Project Launch Pad - Design Efforts for New Facility in Everett, WA
- Mike Vandiver - Site Head, Launch Pad Manufacturing, Executive Director, Manufacturing, Seattle Genetics
8:50am - 9:30am40 mins
Plenary Session
Bioprocess Engineering Strategies to Enhance Productivity and Yield of the Pinnacle ™ Producer Cell Line Platform, Enabling High Productivity at 2000L Scale
- James Warren - Vice President, Pharmaceutical Development, Ultragenyx Gene Therapy
9:30am - 10:25am55 mins
Networking Break
Networking Refreshment Break in Poster & Exhibit Hall
9:40am - 10:00am20 mins
BPI Theatre
Simplifying Upstream Process Intensification with an Optimized Cell Retention Solution
- Haley Matthews - Applications Engineer II, MilliporeSigma
10:00am - 10:20am20 mins
BPI Theatre
Introduction of 2nd generation of Cobetter virus removal filters PES-Plus
- Yingqing Huang, PhD - Managing Director, Cobetter North America Inc
10:25am - 10:30am5 mins
Cell Line Development & Engineering
Chairperson's Remarks
- Barbara Tevelev - Senior Scientist Molecular Discovery, Pfizer
10:25am - 10:30am5 mins
Cell Culture
Chairperson's Remarks
10:25am - 10:30am5 mins
Recovery & Purification
Chairperson's Remarks
10:25am - 10:30am5 mins
Manufacturing Strategy & Bioprocessing 4.0
Chairperson's Remarks
- Swapnil Bhargava - Senior Vice President, CMC Development and GMP Manufacturing, AbCellera
10:25am - 10:30am5 mins
Cell & Gene Therapy Manufacturing
Chairperson's Remarks
- Justin Skoble - Vice President of Technical Operations, Caribou Biosciences
10:25am - 10:30am5 mins
Next Generation CAR & T Cell Therapies
Chairperson's Remarks
10:25am - 10:35am10 mins
BPI Theatre
Technology Showcase – A Representative from Trince Bio
10:30am - 11:00am30 mins
Cell Line Development & Engineering
Patching Automation Gaps in Cell Line Development Workflows
- Anna Venne - Associate Scientist III, Biogen
10:30am - 11:00am30 mins
Cell Culture
Strategy for Upstream Process Data Integration
- Curtis Lin, PhD - Associate Director, Seattle Genetics
10:30am - 11:00am30 mins
Recovery & Purification
Method Development for Optimal Host Cell Protein Monitoring
- Olivier Ducoudret, PhD - Senior Scientist, Macrogenics
10:30am - 11:00am30 mins
Manufacturing Strategy & Bioprocessing 4.0
Accelerating process development with machine-learning, hybrid modeling and digital twins
- Michael Sokolov - COO, DataHow
10:30am - 11:00am30 mins
Cell & Gene Therapy Manufacturing
Keynote: Next Generation Process Development and Manufacturing for Gene Therapies – Improving Efficiencies and Reducing Cost of Goods
- Raghu Shivappa - Vice President, Head of Global Biologics and Gene Therapy Process Development, Takeda
10:30am - 11:00am30 mins
Next Generation CAR & T Cell Therapies
ELiPSE-1: FIH trial of CNTY-101, an allo-evasion equipped CAR-iNK product for CD19 positive NHL
- Nikolaus Trede - Vice President of Early Clinical Development, Century Theaputics, Inc.
10:35am - 10:45am10 mins
BPI Theatre
Technology Showcase – A Representative from Pathoquest
10:45am - 10:50am5 mins
BPI Theatre
Break
10:50am - 11:30am40 mins
BPI Theatre
Panel Discussion: How Manufacturing Operations can have a Meaningful Impact on Corporate Sustainability Commitments?
11:00am - 11:30am30 mins
Cell Line Development & Engineering
Evaluating Use of Stable Pool or Pool of Clones for Tox Production to Enable Speed to Clinic
- Jessica Pan - Associate Principal Scientist, Merck
11:00am - 11:30am30 mins
Cell Culture
Analysis of Covid Spike Protein Variants with a Novel Fluorescent Label
- Michael Butler, Ph.D. - Principal Investigator, Cell Technology, National Institute of Bioprocessing Research & Training (NIBRT)
11:00am - 11:30am30 mins
Recovery & Purification
Understanding HCP Contamination
- Abraham Lenhoff - Allan P. Colburn Professor of Chemical Engineering, University of Delaware
11:00am - 11:30am30 mins
Manufacturing Strategy & Bioprocessing 4.0
End-End Digital Twins for Manufacturing
- Christoph Herwig - Head Biochemical Engineering, Institute of Chemical Engineering, TU Wien, Austria
11:00am - 11:30am30 mins
Cell & Gene Therapy Manufacturing
The Path to Commercialization of an Allogeneic Stem Cell Therapy: a MultiStem© Perspective
- Senthil Ranganathan - Vice President, Technical Operations, Athersys
11:00am - 11:30am30 mins
Next Generation CAR & T Cell Therapies
Multi-Antigen Targeting and Redirection with a Novel Universal Immune Receptor
- Daniel Shelly, PhD - Vice President Business Development and Alliances, Prescient Therapeutics
11:30am - 12:00pm30 mins
Cell Line Development & Engineering
Scientific Track Presentation - A Representative from Berkeley Lights
11:30am - 12:00pm30 mins
Cell Culture
Thermo Scientific™ DynaSpin™ Single-Use Centrifuge: Simplified, Automated, Intensified Processing—a Data–Rich Solution to Harvest Scale Out
- Jordan Cobia - Product Manager, Thermo Fisher Scientific
11:30am - 12:00pm30 mins
Recovery & Purification
Scientific Track Presentation: A Representative from Beckman Coulter
11:30am - 12:00pm30 mins
Manufacturing Strategy & Bioprocessing 4.0
Scientific Track Presentation: A Representative from Novilytic
11:30am - 12:00pm30 mins
Cell & Gene Therapy Manufacturing
Scientific Track Presentation - A Representative from Sartorius
11:35am - 11:55am20 mins
BPI Theatre
BPI TV Interview with c-Lecta
12:00pm - 1:25pm85 mins
Lunch
Luncheon in the Poster & Exhibit Hall
12:00pm - 12:05pm5 mins
BPI Theatre
Break
12:05pm - 12:10pm5 mins
BPI Theatre
Technology Showcase: A Representative from CerCell
12:10pm - 12:20pm10 mins
BPI Theatre
Technology Showcase: A Representative from BASF
12:20pm - 12:30pm10 mins
BPI Theatre
Technology Showcase
12:30pm - 12:40pm10 mins
BPI Theatre
Technology Showcase
12:40pm - 1:15pm35 mins
BPI Theatre
Break
1:15pm - 1:25pm10 mins
BPI Theatre
Diversity, Equity, and Inclusion in Bioprocessing Sector
1:25pm - 1:30pm5 mins
Cell Line Development & Engineering
Chairperson's Remarks
- Barbara Tevelev - Senior Scientist Molecular Discovery, Pfizer
1:25pm - 1:30pm5 mins
Cell Culture
Chairperson's Remarks
1:25pm - 1:30pm5 mins
Recovery & Purification
Chairperson's Remarks
1:25pm - 1:30pm5 mins
Manufacturing Strategy & Bioprocessing 4.0
Chairperson's Remarks
- Swapnil Bhargava - Senior Vice President, CMC Development and GMP Manufacturing, AbCellera
1:25pm - 1:30pm5 mins
Cell & Gene Therapy Manufacturing
Chairperson's Remarks
- Justin Skoble - Vice President of Technical Operations, Caribou Biosciences
1:25pm - 1:30pm5 mins
Next Generation CAR & T Cell Therapies
Chairperson's Remarks
1:25pm - 1:55pm30 mins
BPI Theatre
Diversity, Equity, and Inclusion in Bioprocessing Sector Continued
1:30pm - 2:00pm30 mins
Cell Line Development & Engineering
Accelerate FIH Timeline for Biologics Pipeline Development with Berkeley Lights Beacon Technology
- Falguni Patel - Senior Scientist II, Cell Line Development Group BioProcess Development, Abbvie
1:30pm - 2:00pm30 mins
Cell Culture
End-To-End Data Paradigm for Cell Line Development
- Jasmine Tat - Senior Associate Data Scientist, Amgen
1:30pm - 2:00pm30 mins
Recovery & Purification
Water Conservation and Recycling Strategies in Bioprocessing
- Alois Jungbauer - Professor, Institute of Bioprocess Science and Engineering Department of Biotechnology, University of Natural Resources and Life Sciences Vienna
1:30pm - 2:00pm30 mins
Manufacturing Strategy & Bioprocessing 4.0
Process Analytical Technology and its role in Next Generation Manufacturing
- Jeremy Springall - Associate Director, Astrazeneca
1:30pm - 2:00pm30 mins
Cell & Gene Therapy Manufacturing
Overcoming the Scale Up and Manufacturing Challenges of Next Generation “Off the Shelf” Allogeneic Cell Therapies
- Keith Wilson - Director, Manufacturing Science and Technology, Century Therapeutics, Inc., USA
1:30pm - 2:00pm30 mins
Next Generation CAR & T Cell Therapies
Artificial Membrane Binding Proteins: Precision Membrane Engineering of Cell Therapy for Cancer
- Kevin Brady, PhD - Vice President, Preclinical, Cytoseek
1:55pm - 2:00pm5 mins
BPI Theatre
Break
2:00pm - 2:30pm30 mins
Cell Line Development & Engineering
Production of afucosylated antibodies in CHO cells by co-expression of an anti-FUT8 intrabody
- Laurence Delafosse - Team Lead - Rapid Protein Production, Human Health Therapeutics, Research Center of the National Research Council of Canada
2:00pm - 2:30pm30 mins
Cell Culture
Cell Line Engineering to Improve Purification of Bifunctional Fc Fusion Proteins
- Vishruti Makani - Associate Director – CLD and R&D Support, Shattuck Labs, Inc.
2:00pm - 2:30pm30 mins
Recovery & Purification
Resin Reuse Across Products
- Denise Tanis - Senior Engineer, Alexion Pharmaceuticals
2:00pm - 2:30pm30 mins
Manufacturing Strategy & Bioprocessing 4.0
Management of Raw Materials in Response to Disruptions
- Shreya Munjal - Engineer in Global MSAT and Engineering, Genentech
2:00pm - 2:30pm30 mins
Cell & Gene Therapy Manufacturing
Case Study: iPSC Based Cell Therapies - Tackling Scale Up, GMP and Downstream Hurdles
- Richard Anderson - Senior Director, Fate Therapeutics Inc
2:00pm - 2:30pm30 mins
Next Generation CAR & T Cell Therapies
Improving outcomes for solid tumour treatment using allogeneic CAR-TCR-Ts
- Devon Shedlock - Chief Scientific Officer, Cell Therapy, Poseida Therapeutics
2:00pm - 2:40pm40 mins
BPI Theatre
Panel Discussion: Security of Supply Chain
2:30pm - 3:00pm30 mins
Cell Line Development & Engineering
Increased Efficiency of Clonal Selection and Shortened CLD Workflows with Solentim ICON
- Kayla Bean, PhD - Senior Scientist, Cell Line Development, AGC Biologics
2:30pm - 3:00pm30 mins
Cell Culture
Scientific Track Presentation
2:30pm - 3:00pm30 mins
Recovery & Purification
Scientific Track Presentation - A Representative from 3M
2:30pm - 3:00pm30 mins
Manufacturing Strategy & Bioprocessing 4.0
Economic Analyses of Build vs Buy vs Blend Options for Early Phase Biopharmaceutical Manufacturing
- Ravi Samavedam - Chief Innovation Officer (CINO), Azzur Group
2:30pm - 3:00pm30 mins
Cell & Gene Therapy Manufacturing
Scientific Track Presentation
2:30pm - 3:00pm30 mins
Next Generation CAR & T Cell Therapies
Scientific Track Presentation
2:40pm - 3:00pm20 mins
BPI Theatre
Break
3:00pm - 4:00pm60 mins
Networking Break
Networking Refreshment Break in the Exhibit & Poster Hall
3:05pm - 3:15pm10 mins
BPI Theatre
Technology Showcase
3:15pm - 3:25pm10 mins
BPI Theatre
Technology Showcase
3:25pm - 3:35pm10 mins
BPI Theatre
Technology Showcase
3:35pm - 3:55pm20 mins
BPI Theatre
Technology Showcase
3:55pm - 4:00pm5 mins
BPI Theatre
Break
4:00pm - 4:30pm30 mins
Cell Line Development & Engineering
Cell Line Characterization for Cell Line Selection Using Next-Generation Sequencing and EpiGenetic Sequencing
- Christina Tsai, PhD - Senior Scientist, IGM Biosciences
4:00pm - 4:30pm30 mins
Cell Culture
Feeding the Masses: Cultivated Meat Shifts the Bioprocess Paradigm to Edible Products at Unprecedented Volumes
- Mark Juhas - Director, UPSIDE Foods
4:00pm - 4:30pm30 mins
Recovery & Purification
Smart Platform for Fast Development of Small- Scale Integrated Continuous Downstream Processes
- Bernt Nilsson - Professor, Chemical Engineering, Lund University
4:00pm - 4:30pm30 mins
Manufacturing Strategy & Bioprocessing 4.0
Key Attributes and Intangible Considerations of Cell and Gene Therapy CDMO Selection by Innovator Companies
- Joseph Rininger, Ph.D. - Managing Director, Cell and Gene Therapy, Latham Biopharma
4:00pm - 4:30pm30 mins
Cell & Gene Therapy Manufacturing
Genome Engineering Strategies for Allogeneic CAR-T Cell Therapies to Improve Efficacy and Durability
- Justin Skoble - Vice President of Technical Operations, Caribou Biosciences
4:00pm - 4:30pm30 mins
Next Generation CAR & T Cell Therapies
Engineering T cells to overcome the tumor microenvironment
- Jill Mooney - SVP, Research and Development, ElevateBio
4:00pm - 4:30pm30 mins
BPI Theatre
CIRM: Accelerating Cell and Gene Therapy Development in California
- Shyam Patel - Senior Director of Business Development & Alliance Management, California Institute for Regenerative Medicine
4:30pm - 5:00pm30 mins
Cell Line Development & Engineering
Applications of next generation sequencing to benefit the development and characterization of manufacturing Chinese hamster ovary (CHO) cell lines
- Jie Zhu, Ph.D. - R&D Director, AstraZeneca
4:30pm - 5:00pm30 mins
Cell Culture
Cell Lines for Cultured Meat: What can we learn?
- Lauran Madden, PhD - Chief Technology Officer, BlueNalu
4:30pm - 5:00pm30 mins
Recovery & Purification
Using Flow PPX for Continuous Processing
- Aishwarya Ramanan - Senior Research Associate, Seattle Genetics
4:30pm - 5:00pm30 mins
Manufacturing Strategy & Bioprocessing 4.0
Please Visit Cell & Gene Therapy for this Session
4:30pm - 5:00pm30 mins
Cell & Gene Therapy Manufacturing
Panel Discussion: CGT CDMO Selection and Manufacturing Best Practices
- Mia Wang - Former Senior Director, Technical Operations, Sana Biotechnology
- Yuyi Shen, PhD - Sr. Dir, PD, MFG & Supply Chain, Abcuro
- Joseph Rininger, Ph.D. - Managing Director, Cell and Gene Therapy, Latham Biopharma
4:30pm - 5:00pm30 mins
Next Generation CAR & T Cell Therapies
Potency enhancement of CAR Ts with new genetic tools and testing quickly in clinical trials
- Eric Althoff Ph.D - Director of Business Development, Seattle Children's Therapeutics
5:00pm - 6:30pm90 mins
Outdoor Evening Drinks Reception
Get the latest event updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats